EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|83|5|248-256

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.5, 2012-09, pp. : 248-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial

By Ku Geoffrey Y   Lima Jopes Jr Gilberto de  

Therapy, Vol. 8, Iss. 1, 2011-01 ,pp. : 55-61

Future Medicine

Access to resources Recommend Favorite

Epidemiology of EML4–ALK translocations in a small, German non-small-cell lung cancer patient cohort

By Schildgen Verena   Lochi Vincenza   Lüsebrink Jessica   Brockmann Michael   Schildgen Oliver  

Personalized Medicine, Vol. 9, Iss. 8, 2012-11 ,pp. : 801-803

Future Medicine

Access to resources Recommend Favorite

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3146-3156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer

By  

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2299-2307

John Wiley & Sons Inc

Access to resources Recommend Favorite